<DOC>
	<DOCNO>NCT02575534</DOCNO>
	<brief_summary>The aim study determine anti-arrhythmic drug sodium channel-blocking mechanism exert detrimental electromechanical effect cardiac function patient depend upon baseline intraventricular conduction leave ventricular function .</brief_summary>
	<brief_title>Acute Mechanical Response Anti-arrhythmic Drug Therapy</brief_title>
	<detailed_description>Amiodarone therapy use frequently control ventricular arrhythmia patient receive painful shock implantable cardioverter-defibrillator ( ICD ) . Data post-myocardial infarction ( MI ) patient ICD patient suggest amiodarone mortality-neutral ; neither confers increase decreased mortality . However , data derive patient largely normal intraventricular conduction , manifest QRS complex duration surface ECG &lt; 120 ms. Amiodarone , addition potassium-channel block effect , sodium channel-blocker . Because sodium channel mediate cardiac depolarization , QRS complex &gt; 120 m indicative abnormal depolarization , amiodarone may benign patient conduction defect . Patients cardiac resynchronization therapy-defibrillators ( CRT-D ) , abnormal baseline intraventricular conduction , may therefore adversely affected amiodarone . Anecdotal clinical data suggest may case , question amiodarone 's cardiac safety profile CRT patient never study .</detailed_description>
	<mesh_term>Anti-Arrhythmia Agents</mesh_term>
	<mesh_term>Procainamide</mesh_term>
	<criteria>Implanted cardiac device require generator change new device Able give inform consent Current membraneactive antiarrhythmic Glomerular filtration rate ( GRF ) &lt; 30 milliliter ( mL ) /min MAP &lt; 60 mmHg Known intolerance procainamide Pregnancy Age &lt; 18 &gt; 85 year old Baseline QT interval &gt; 480 m ( 500 ms pace )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>anti-arrhythmic therapy</keyword>
</DOC>